Cargando…
Clinical guideline SEOM: cancer of unknown primary site
Cancer of unknown primary site is a histologically confirmed cancer which is manifested in advanced stage, with no identifiable primary site after the use of standard diagnostic procedures. Patients are initially placed into one of categories based upon the examination of the initial biopsy: adenoca...
Autores principales: | Collado Martín, R., García Palomo, A., de la Cruz Merino, L., Borrega García, P., Barón Duarte, F. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239766/ https://www.ncbi.nlm.nih.gov/pubmed/25392080 http://dx.doi.org/10.1007/s12094-014-1244-0 |
Ejemplares similares
-
SEOM clinical guideline on unknown primary cancer (2017)
por: Losa, F., et al.
Publicado: (2017) -
SEOM—GECOD clinical guideline for unknown primary cancer (2021)
por: Losa, Ferrán, et al.
Publicado: (2022) -
SEOM clinical guidelines in metastatic breast cancer 2015
por: Gavilá, J., et al.
Publicado: (2015) -
SEOM clinical guidelines on cardiovascular toxicity (2018)
por: Virizuela, J. A., et al.
Publicado: (2019) -
SEOM clinical guidelines for the treatment of Hodgkin’s lymphoma
por: Rueda Domínguez, A., et al.
Publicado: (2015)